FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2396610918> ?p ?o ?g. }

• W2396610918 endingPage "88" @default.
• W2396610918 startingPage "77" @default.
• W2396610918 abstract "Thirty-four subjects with symptomatic HIV-1 infection, p24 antigenaemia, and CD4 cell counts > 200/mm3 were randomly assigned to receive treatment with either zidovudine (ZDV) orally, interferon-alpha (IFN-alpha) subcutaneously, or both at respective low (200 mg ZDV/ 2 million international units IFN-alpha (MIU)), middle (400 mg/4 MIU) or high (600 mg/6 MIU) daily dose levels for 12 weeks. Thereafter, all patients received combination therapy at the initially assigned dose level to a total of 96 weeks. This design permitted analysis by the combination index (CI) method, which demonstrated antiretroviral synergy between ZDV and IFN-alpha with respect to p24 antigen suppression. Over the first 12 weeks, combination therapy was acceptably tolerated, more so than IFN-alpha monotherapy, and it was significantly more active in suppressing antigenaemia than either of the monotherapies. Similarly, the high-dose combination was the most active dose level over weeks 12 to 96. Combination ZDV/IFN-alpha at the optimal dose level defined by this trial merits further study. In addition, the CI design strategy employed here may be useful for the investigation of new antiretroviral combinations." @default.
• W2396610918 created "2016-06-24" @default.
• W2396610918 creator A5000316277 @default.
• W2396610918 creator A5001621686 @default.
• W2396610918 creator A5004476982 @default.
• W2396610918 creator A5005048904 @default.
• W2396610918 creator A5005980581 @default.
• W2396610918 creator A5018364255 @default.
• W2396610918 creator A5024135068 @default.
• W2396610918 creator A5026201022 @default.
• W2396610918 creator A5044359468 @default.
• W2396610918 creator A5048224604 @default.
• W2396610918 creator A5052252975 @default.
• W2396610918 creator A5053667369 @default.
• W2396610918 creator A5065074370 @default.
• W2396610918 creator A5065276262 @default.
• W2396610918 creator A5066618683 @default.
• W2396610918 creator A5067237789 @default.
• W2396610918 creator A5071884473 @default.
• W2396610918 creator A5075931137 @default.
• W2396610918 creator A5078945580 @default.
• W2396610918 creator A5079435976 @default.
• W2396610918 creator A5091194834 @default.
• W2396610918 date "1996-04-01" @default.
• W2396610918 modified "2023-09-27" @default.
• W2396610918 title "Synergy, activity and tolerability of zidovudine and interferon-alpha in patients with symptomatic HIV-1 infection: AIDS Clincal Trial Group 068." @default.
• W2396610918 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11321183" @default.
• W2396610918 hasPublicationYear "1996" @default.
• W2396610918 type Work @default.
• W2396610918 sameAs 2396610918 @default.
• W2396610918 citedByCount "6" @default.
• W2396610918 countsByYear W23966109182015 @default.
• W2396610918 countsByYear W23966109182016 @default.
• W2396610918 crossrefType "journal-article" @default.
• W2396610918 hasAuthorship W2396610918A5000316277 @default.
• W2396610918 hasAuthorship W2396610918A5001621686 @default.
• W2396610918 hasAuthorship W2396610918A5004476982 @default.
• W2396610918 hasAuthorship W2396610918A5005048904 @default.
• W2396610918 hasAuthorship W2396610918A5005980581 @default.
• W2396610918 hasAuthorship W2396610918A5018364255 @default.
• W2396610918 hasAuthorship W2396610918A5024135068 @default.
• W2396610918 hasAuthorship W2396610918A5026201022 @default.
• W2396610918 hasAuthorship W2396610918A5044359468 @default.
• W2396610918 hasAuthorship W2396610918A5048224604 @default.
• W2396610918 hasAuthorship W2396610918A5052252975 @default.
• W2396610918 hasAuthorship W2396610918A5053667369 @default.
• W2396610918 hasAuthorship W2396610918A5065074370 @default.
• W2396610918 hasAuthorship W2396610918A5065276262 @default.
• W2396610918 hasAuthorship W2396610918A5066618683 @default.
• W2396610918 hasAuthorship W2396610918A5067237789 @default.
• W2396610918 hasAuthorship W2396610918A5071884473 @default.
• W2396610918 hasAuthorship W2396610918A5075931137 @default.
• W2396610918 hasAuthorship W2396610918A5078945580 @default.
• W2396610918 hasAuthorship W2396610918A5079435976 @default.
• W2396610918 hasAuthorship W2396610918A5091194834 @default.
• W2396610918 hasConcept C126322002 @default.
• W2396610918 hasConcept C141071460 @default.
• W2396610918 hasConcept C197934379 @default.
• W2396610918 hasConcept C203014093 @default.
• W2396610918 hasConcept C2775944032 @default.
• W2396610918 hasConcept C2776178377 @default.
• W2396610918 hasConcept C2776452011 @default.
• W2396610918 hasConcept C2776999253 @default.
• W2396610918 hasConcept C2778375690 @default.
• W2396610918 hasConcept C2780216070 @default.
• W2396610918 hasConcept C2780727368 @default.
• W2396610918 hasConcept C2781228144 @default.
• W2396610918 hasConcept C2909179924 @default.
• W2396610918 hasConcept C3013748606 @default.
• W2396610918 hasConcept C49453240 @default.
• W2396610918 hasConcept C64943373 @default.
• W2396610918 hasConcept C71924100 @default.
• W2396610918 hasConcept C90924648 @default.
• W2396610918 hasConcept C98274493 @default.
• W2396610918 hasConceptScore W2396610918C126322002 @default.
• W2396610918 hasConceptScore W2396610918C141071460 @default.
• W2396610918 hasConceptScore W2396610918C197934379 @default.
• W2396610918 hasConceptScore W2396610918C203014093 @default.
• W2396610918 hasConceptScore W2396610918C2775944032 @default.
• W2396610918 hasConceptScore W2396610918C2776178377 @default.
• W2396610918 hasConceptScore W2396610918C2776452011 @default.
• W2396610918 hasConceptScore W2396610918C2776999253 @default.
• W2396610918 hasConceptScore W2396610918C2778375690 @default.
• W2396610918 hasConceptScore W2396610918C2780216070 @default.
• W2396610918 hasConceptScore W2396610918C2780727368 @default.
• W2396610918 hasConceptScore W2396610918C2781228144 @default.
• W2396610918 hasConceptScore W2396610918C2909179924 @default.
• W2396610918 hasConceptScore W2396610918C3013748606 @default.
• W2396610918 hasConceptScore W2396610918C49453240 @default.
• W2396610918 hasConceptScore W2396610918C64943373 @default.
• W2396610918 hasConceptScore W2396610918C71924100 @default.
• W2396610918 hasConceptScore W2396610918C90924648 @default.
• W2396610918 hasConceptScore W2396610918C98274493 @default.
• W2396610918 hasIssue "2" @default.
• W2396610918 hasLocation W23966109181 @default.
• W2396610918 hasOpenAccess W2396610918 @default.
• W2396610918 hasPrimaryLocation W23966109181 @default.
• W2396610918 hasRelatedWork W1259023245 @default.

• next